Subsequent to SCOPE-1, several other studies have reported outcomes from EGFR inhibition and CRT in oesophageal cancer (Ruhstaller et al, 2011; Becerra et al, 2013; Meng et al, 2013; Ubink et al, 2014). Here, EGFR is linked to carcinoma of esophagus.